Immediate Impact
2 by Nobel laureates 53 standout
Citing Papers
Accelerating antiviral drug discovery: lessons from COVID-19
2023 Standout
A review of 2022 Chinese clinical guidelines on the management of hepatocellular carcinoma: updates and insights
2023 Standout
Works of C. Cooper being referenced
Safety and efficacy of Ombitasvir, Paritaprevir/Ritonavir and Dasabuvir with or without ribavirin in chronic hepatitis C patients receiving opioid substitution therapy: a pooled analysis across 12 clinical trials
2017
940 SAFETY, TOLERABILITY AND PHARMACOKINETICS OF THE HCV POLYMERASE INHIBITOR VCH-222 FOLLOWING SINGLE DOSE ADMINISTRATION IN HEALTHY VOLUNTEERS AND ANTIVIRAL ACTIVITY IN HCV-INFECTED INDIVIDUALS
2009
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| C. Cooper | 239 | 237 | 129 | 20 | 329 | |
| Paula Tuma | 268 | 260 | 105 | 22 | 370 | |
| R. Bravo | 287 | 254 | 124 | 14 | 350 | |
| S Echevarrı́a | 145 | 195 | 116 | 29 | 366 | |
| Antonio Carlotto | 258 | 313 | 62 | 13 | 349 | |
| Paola Zuccalà | 126 | 122 | 76 | 13 | 265 | |
| Charlotte H. S. B. van den Berg | 215 | 246 | 84 | 15 | 291 | |
| L. Fonquernie | 99 | 167 | 86 | 22 | 255 | |
| Emma Page | 244 | 253 | 130 | 16 | 365 | |
| S Žerjav | 69 | 200 | 138 | 28 | 340 | |
| Ángeles Castro | 284 | 261 | 108 | 19 | 346 |
All Works
Loading papers...